The nature of the peptide/MHC ligand involved in positive selection

By Hogquist K.A.   Bevan M.J.  

Seminars in Immunology, Vol. 8, Iss. 2, 1996-02 ,pp. : 63-68

Academic Press

Access to resources Recommend Favorite

Quantitative aspects of T cell activation—peptide generation and editing by MHC class I molecules

By Stevanovic S.   Schild H.  

Seminars in Immunology, Vol. 11, Iss. 6, 1999-12 ,pp. : 375-384

Academic Press

Access to resources Recommend Favorite

Ii-Key/HER-2/neu MHC class-II antigenic epitope vaccine peptide for breast cancer

By Gillogly Michael   Kallinteris Nikoletta   Xu Minzhen   Gulfo Joseph   Humphreys Robert   Murray James  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 6, 2004-06 ,pp. : 490-496

Springer Publishing Company

Access to resources Recommend Favorite

The structure of MHC class II: a role for dimer of dimers

By Schafer P.H.   Pierce S.K.   Jardetzky T.S.  

Seminars in Immunology, Vol. 7, Iss. 6, 1995-12 ,pp. : 389-398

Academic Press

Access to resources Recommend Favorite

Introduction: MHC class II-restricted antigen presentation

By Miller J.   Sant A.J.  

Seminars in Immunology, Vol. 7, Iss. 6, 1995-12 ,pp. : 343-346

Academic Press

Access to resources Recommend Favorite